Protective antioxidant and antiapoptotic effects of ZnCl2 in rat pancreatic islets cultured in low and high glucose concentrations

PLoS One. 2012;7(10):e46831. doi: 10.1371/journal.pone.0046831. Epub 2012 Oct 3.

Abstract

Aim/hypothesis: Rat pancreatic islet cell apoptosis is minimal after prolonged culture in 10 mmol/l glucose (G10), largely increased in 5 mmol/l glucose (G5) and moderately increased in 30 mmol/l glucose (G30). This glucose-dependent asymmetric V-shaped profile is preceded by parallel changes in the mRNA levels of oxidative stress-response genes like Metallothionein 1a (Mt1a). In this study, we tested the effect of ZnCl(2), a potent inducer of Mt1a, on apoptosis, mitochondrial oxidative stress and alterations of glucose-induced insulin secretion (GSIS) induced by prolonged exposure to low and high vs. intermediate glucose concentrations.

Methods: Male Wistar rat islets were cultured in RPMI medium. Islet gene mRNA levels were measured by RTq-PCR. Apoptosis was quantified by measuring islet cytosolic histone-associated DNA fragments and the percentage of TUNEL-positive β-cells. Mitochondrial thiol oxidation was measured in rat islet cell clusters expressing "redox sensitive GFP" targeted to the mitochondria (mt-roGFP1). Insulin secretion was measured by RIA.

Results: As observed for Mt1a mRNA levels, β-cell apoptosis and loss of GSIS, culture in either G5 or G30 vs. G10 significantly increased mt-roGFP1 oxidation. While TPEN decreased Mt1a/2a mRNA induction by G5, addition of 50-100 µM ZnCl(2) to the culture medium strongly increased Mt1a/2a mRNA and protein levels, reduced early mt-roGFP oxidation and significantly decreased late β-cell apoptosis after prolonged culture in G5 or G30 vs. G10. It did not, however, prevent the loss of GSIS under these culture conditions.

Conclusion: ZnCl(2) reduces mitochondrial oxidative stress and improves rat β-cell survival during culture in the presence of low and high vs. intermediate glucose concentrations without improving their acute GSIS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Apoptosis / drug effects*
  • Cation Transport Proteins / genetics
  • Cation Transport Proteins / metabolism
  • Cell Culture Techniques
  • Chelating Agents / pharmacology
  • Chlorides / pharmacology*
  • Cytoprotection / drug effects*
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • Glucose / pharmacology*
  • Insulin / metabolism
  • Insulin Secretion
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism
  • Male
  • Metallothionein / genetics
  • Metallothionein / metabolism
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Oxidation-Reduction / drug effects
  • Oxidative Stress / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Wistar
  • Sulfhydryl Compounds / metabolism
  • Time Factors
  • Zinc Compounds / pharmacology*
  • Zinc Transporter 8

Substances

  • Antioxidants
  • Cation Transport Proteins
  • Chelating Agents
  • Chlorides
  • Insulin
  • RNA, Messenger
  • Slc30a8 protein, rat
  • Sulfhydryl Compounds
  • Zinc Compounds
  • Zinc Transporter 8
  • Slc30a1 protein, rat
  • zinc chloride
  • Metallothionein
  • Glucose

Grants and funding

This work was supported by the Fonds de la Recherche Scientifique-FNRS (Belgium) (grants 3.4516.09, 1.5012.11 and 3.4521.12) and the Société Francophone du Diabète (France). JD is recipient of a fellowship from the Fonds pour la formation à la Recherche dans l’Industrie et dans l’Agriculture, Belgium. JCJ is Research Director of the Fonds de la Recherche Scientifique-FNRS, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.